beta
Trial Radar AI

Showing clinical trials for Neoplasms, Endometrial Neoplasms matching location: France.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

18 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Neoplasms, Endometrial Neoplasms
×
 
Keywords
Ovarian Cancer
×
 
Location
France
×
 
Phase
Phase 2
×
 
Study Title
Status
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341
Recruiting
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. (EZHiSWITCH) NCT07303387
Not yet recruiting
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) NCT04956640
Recruiting
GEN1047 for Solid Tumors - First in Human (FIH) Trial NCT05180474
Active, not recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types NCT04300556
Recruiting
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064
Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib (ROCSAN) NCT03651206
Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) NCT05489211
Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab NCT04590326
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) (panSOHO) NCT06760819
Recruiting
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors (PIKALO-1) NCT05768139
Recruiting
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations (DPT01) NCT04639219
Active, not recruitingResults Posted
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) NCT04585750
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors NCT06128551
Recruiting